The central clinical idea: when mitochondrial ATP production falls and oxidative stress rises, the brain may lose the energy and antioxidant reserve needed to regulate neurotransmission, maintain cell membranes, recycle methionine, produce SAM, clear adenosine and homocysteine, build glutathione and tolerate medications or supplements
The documented starting dose is 2,667 mcg, which is 2.667 mg: 2.667 mg 26.67 mg/mL = 0.10 mL Step 3 Convert to insulin-syringe units A U-100 insulin syringe reads 100 units per mL, so multiply the millilitres by 100: 0.10 mL 100 = 10 units So the documented KLOW dose is 0.10 mL = 10 units on a U-100 syringe
Chemistry and antihypertensive effects of tempol and other nitroxides
But the glucagon component adds something Mounjaro cannot: increased energy output
PT-141 (Bremelanotide) is a synthetic peptide derived from Melanotan II
10, S95S101